Company / SG&A Expense
KORU Medical Systems, Inc. SG&A Expense History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$21.6M
FY2025
5-year range
$12.0M / $21.6M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $21M to $22M over the past 2 years.
Based on SEC 10-K filings.
$22M in FY2025 with a 10-year CAGR of +16.3%.
Increased from $21M to $22M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- +16.3%
Key checks
Key Insights
- 5-year CAGR of +17.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 6.2% year-over-year.
- Lowest sg&a expense in the period was in FY2013.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.6M | +6.2% |
| FY2024 | $20.4M | -1.2% |
| FY2023 | $20.6M | +15.4% |
| FY2022 | $17.9M | +48.5% |
| FY2021 | $12.0M | +23.1% |
| FY2020 | $9.8M | +19.2% |
| FY2019 | $8.2M | +37.9% |
| FY2017 | $5.9M | +24.1% |
| FY2015 | $4.8M | +35.1% |
| FY2013 | $3.5M | +33.4% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026